ExoCXCR4+TRAIL has been used as a cooperative agent with carboplatin against brain metastasis of breast cancer in vivo, providing the possibility of using this agent as a novel biological method for enhancing the treatment of brain metastases of breast cancer. Here, TNFSF10 is linked to breast cancer.